SCHEMBL353231

SCHEMBL353231

CCc1ncccc1C(N)=O

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.55
ALDH1A1 P00352 1/20 0.55
HPGD P15428 1/20 0.55
HSD17B10 Q99714 1/20 0.55
PARP1 P09874 3/20 0.51
SYK P43405 6/20 0.47
RAB9A P51151 2/20 0.46
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
AHR P35869 1/20 0.46
P2RX7 Q99572 1/20 0.46
NAPRT Q6XQN6 1/20 0.43
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30011332 1.00 KDM4E (0.55) KDM4EALDH1A1HPGDHSD17B10PARP1
Ammonia Solution, Strong SCHEMBL28941143 0.98 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10PARP1
Fluoride SCHEMBL11495081 0.98 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10PARP1
SCHEMBL2497122 0.86 KDM4E (0.56) KDM4EALDH1A1HPGDHSD17B10PARP1
SCHEMBL9768749 0.85 P2RX7 (0.44) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL29117074 0.84 ALDH1A1 (0.43) KDM4EALDH1A1HPGDHSD17B10PARP1
SCHEMBL31337410 0.84 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10SYK
SCHEMBL7256602 0.83 P2RX7 (0.43) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL1937751 0.83 PARP1 (0.53) KDM4EALDH1A1HPGDHSD17B10PARP1
SCHEMBL497429 0.83 PARP1 (0.53) KDM4EALDH1A1HPGDHSD17B10PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 412 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250161201-A1 COSMETIC COMPOSITION THE BOOTS COMPANY PLC (GB) 2025-05-22 US claimed
EP-4479146-A1 COSMETIC COMPOSITION The Boots Company PLC (GB) 2024-12-25 EP claimed
CN-118641677-B Detection method for impurities in nikka brake rice raw material 北京京丰制药集团有限公司 2024-11-05 CN claimed
CN-118641677-A Detection method for impurities in nikka brake rice raw material 北京京丰制药集团有限公司 2024-09-13 CN claimed
WO-2023156070-A1 COSMETIC COMPOSITION THE BOOTS COMPANY PLC (GB) 2023-08-24 WO claimed
EP-4021893-A1 PERK INHIBITING COMPOUNDS Hibercell, Inc. (US) 2022-07-06 EP claimed
WO-2021041973-A1 PERK INHIBITING COMPOUNDS HIBERCELL, INC. (US) 2021-03-04 WO claimed
CN-105683179-B inhibitors of plasma kallikrein 卡尔维斯塔制药有限公司 2018-10-26 CN claimed
EP-1560589-B1 NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND NIACINAMIDE ASTION DERMATOLOGY AS (DK) 2006-10-04 EP claimed
US-20060069131-A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives ASTION DERMATOLOGY A/S 2006-03-30 US claimed
CN-1674921-A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives ASTION DERMATOLOGY AS (DK) 2005-09-28 CN claimed
EP-1560589-A1 NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND PYRIDINE CARBOXY DERIVATIVES Astion Dermatology A/S (DK) 2005-08-10 EP claimed
WO-2004000333-A1 NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND PYRIDINE CARBOXY DERIVATIVES ASTION DERMATOLOGY A/S (DK) 2003-12-31 WO claimed
EP-1367985-A2 ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING A SOLID, WATER-SOLUBLE, SKIN ACTIVE AGENT THE PROCTER & GAMBLE COMPANY (US) 2003-12-10 EP claimed
WO-2002069916-A2 ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING A SOLID, WATER-SOLUBLE, SKIN ACTIVE AGENT THE PROCTER & GAMBLE COMPANY (US) 2002-09-12 WO claimed
US-6383476-B1 Anhydrous antiperspirant and deodorant compositions containing a solid, water-soluble, skin active agent THE PROCTER & GAMBLE COMPANY 2002-05-07 US claimed
EP-1094816-A4 BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2001-12-19 EP claimed
EP-1094816-A1 BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-05-02 EP claimed
WO-2000001389-A1 BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB CO. (US) 2000-01-13 WO claimed
EP-4744647-A2 SKIN CARE COMPOSITIONS COMPRISING VITAMIN E AND VITAMIN B3 Colgate-Palmolive Company (US) 2026-05-20 EP disclosed
EP-4724034-A1 SYNERGISTIC ANTIOXIDANT COMPOSITIONS The Procter & Gamble Company (US) 2026-04-15 EP disclosed
US-12583851-B2 Heteroaryl-substituted pyrazine derivatives as pesticides ELANCO ANIMAL HEALTH GMBH (DE) 2026-03-24 US disclosed
WO-2025229086-A1 ADHESIVE COSMETIC COMPOUNDS AND USES THEREOF SKINOSIVE (FR) 2025-11-06 WO disclosed
US-20250312264-A1 Skin Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2025-10-09 US disclosed
US-20250312263-A1 SKIN CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2025-10-09 US disclosed
US-20250270190-A1 KIT INHIBITORS BLUEPRINT MEDICINES CORPORATION 2025-08-28 US disclosed
US-12351580-B2 NLRP3 modulators INNATE TUMOR IMMUNITY, INC. (US) 2025-07-08 US disclosed
US-20250170043-A1 KIT OF COSMETIC COMPOSITIONS THE BOOTS COMPANY PLC (GB) 2025-05-29 US disclosed
US-20250161200-A1 COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE THE BOOTS COMPANY PLC (GB) 2025-05-22 US disclosed
US-20250161201-A1 COSMETIC COMPOSITION THE BOOTS COMPANY PLC (GB) 2025-05-22 US disclosed
US-20250152494-A1 COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE THE BOOTS COMPANY PLC (GB) 2025-05-15 US disclosed
US-20250073142-A1 Personal Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2025-03-06 US disclosed
EP-4479146-A1 COSMETIC COMPOSITION The Boots Company PLC (GB) 2024-12-25 EP disclosed
EP-4479145-A1 COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE The Boots Company PLC (GB) 2024-12-25 EP disclosed
WO-2024254280-A1 SYNERGISTIC ANTIOXIDANT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2024-12-12 WO disclosed
US-20240407990-A1 SYNERGISTIC ANTIOXIDANT COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2024-12-12 US disclosed
CN-119110720-A Cosmetic composition 布茨公司 2024-12-10 CN disclosed
CN-119072299-A Cosmetic composition containing retinoid, centella asiatica extract and dipeptide 布茨公司 2024-12-03 CN disclosed
CN-118641677-B Detection method for impurities in nikka brake rice raw material 北京京丰制药集团有限公司 2024-11-05 CN disclosed
CN-118641677-B Detection method for impurities in nikka brake rice raw material 北京京丰制药集团有限公司 2024-11-05 CN disclosed
US-20240325276-A1 Personal Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2024-10-03 US disclosed
CN-118641677-A Detection method for impurities in nikka brake rice raw material 北京京丰制药集团有限公司 2024-09-13 CN disclosed
CN-118641677-A Detection method for impurities in nikka brake rice raw material 北京京丰制药集团有限公司 2024-09-13 CN disclosed
WO-2024146868-A1 COMPOSITIONS FOR HORMONALLY IMPACTED SKIN THE BOOTS COMPANY PLC (GB) 2024-07-11 WO disclosed
WO-2024146869-A1 COMPOSITIONS FOR HORMONALLY IMPACTED SKIN THE BOOTS COMPANY PLC (GB) 2024-07-11 WO disclosed
EP-4395735-A1 TRANSPARENT COMPOSITION COMPRISING POLYHYDROXY ACID L'OREAL (FR) 2024-07-10 EP disclosed
EP-4392011-A1 SKIN CARE COMPOSITIONS AND METHODS OF USE Colgate-Palmolive Company (US) 2024-07-03 EP disclosed
US-20240189206-A1 Skin Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2024-06-13 US disclosed
CN-117957212-A IL-17A modulators based on phenylacetamide and uses thereof 戴斯阿尔法公司 2024-04-30 CN disclosed
US-11938212-B2 Skin care compositions COLGATE-PALMOLIVE COMPANY (US) 2024-03-26 US disclosed
EP-4337159-A1 COMPOSITION COMPRISING SKIN CARE ACTIVE INGREDIENT AND TWO POLYGLYCERYL FATTY ACID ESTERS L'OREAL (FR) 2024-03-20 EP disclosed
US-20240067649-A1 NLRP3 MODULATORS INNATE TUMOR IMMUNITY INC (US) 2024-02-29 US disclosed
WO-2024014310-A1 COMPOSITION COMPRISING SKIN CARE ACTIVE INGREDIENT OR CELLULOSE COMPOUND L'OREAL (FR) 2024-01-18 WO disclosed
US-20230390178-A1 Skin Care Compositions and Methods of Use COLGATE-PALMOLIVE COMPANY (US) 2023-12-07 US disclosed
WO-2023235544-A1 SKIN CARE COMPOSITIONS AND METHODS OF USE COLGATE-PALMOLIVE COMPANY (US) 2023-12-07 WO disclosed
US-11827632-B2 NLRP3 modulators INNATE TUMOR IMMUNITY, INC (US) 2023-11-28 US disclosed
US-20230320970-A1 Skin Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2023-10-12 US disclosed
WO-2023196200-A1 SKIN CARE COMPOSITIONS COMPRISING VITAMIN E AND VITAMIN B3 COLGATE-PALMOLIVE COMPANY (US) 2023-10-12 WO disclosed
WO-2023196194-A2 SKIN CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2023-10-12 WO disclosed
US-20230320969-A1 Skin Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2023-10-12 US disclosed
EP-4257112-A2 SKIN CARE COMPOSITIONS COMPRISING VITAMIN E AND VITAMIN B3 Colgate-Palmolive Company (US) 2023-10-11 EP disclosed
EP-4257113-A1 SKIN CARE COMPOSITIONS COMPRISING VITAMIN E AND VITAMIN B3 Colgate-Palmolive Company (US) 2023-10-11 EP disclosed
CN-116685338-A Compositions and methods for improving skin health and for treating and preventing diseases, disorders and conditions associated with fungi and other pathogenic microorganisms 德慕拜昂生物科技公司 2023-09-01 CN disclosed
EP-2367852-B1 COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS SEDERMA SA (FR) 2023-08-30 EP disclosed
WO-2023156069-A1 COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE THE BOOTS COMPANY PLC (GB) 2023-08-24 WO disclosed
WO-2023156072-A1 COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE THE BOOTS COMPANY PLC (GB) 2023-08-24 WO disclosed
WO-2023156071-A1 KIT OF COSMETIC COMPOSITIONS THE BOOTS COMPANY PLC (GB) 2023-08-24 WO disclosed
WO-2023156070-A1 COSMETIC COMPOSITION THE BOOTS COMPANY PLC (GB) 2023-08-24 WO disclosed
EP-4210757-A2 EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS Comera Life Sciences, Inc. (US) 2023-07-19 EP disclosed
EP-4203907-A2 STABLE COMPOSITION COMPRISING POLYDATIN L'OREAL (FR) 2023-07-05 EP disclosed
WO-2023119230-A1 COAGULATION PATHWAY AND NICOTINAMIDE-ADENINE DINUCLEOTIDE PATHWAY MODULATING COMPOSITIONS AND METHODS OF THEIR USE L'OREAL (FR) 2023-06-29 WO disclosed
WO-2023113004-A1 NON-STICKY SMOOTH STABLE COMPOSITION L'OREAL (FR) 2023-06-22 WO disclosed
WO-2023068069-A1 COMPOSITION COMPRISING TWO POLYGLYCERYL FATTY ACID ESTERS AND SKINCARE ACTIVE AGENT L'OREAL (FR) 2023-04-27 WO disclosed
US-11622968-B2 Heterocyclic modulators of lipid synthesis SAGIMET BIOSCIENCES INC. (US) 2023-04-11 US disclosed
US-20230101819-A1 SMYD Inhibitors EPIZYME INC (US) 2023-03-30 US disclosed
WO-2023032869-A1 TRANSPARENT COMPOSITION COMPRISING POLYHYDROXY ACID L'OREAL (FR) 2023-03-09 WO disclosed
EP-3744729-B1 PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES SEDERMA SA (FR) 2023-03-01 EP disclosed
US-20230023326-A1 HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES ELANCO ANIMAL HEALTH GMBH (DE) 2023-01-26 US disclosed
WO-2022239257-A1 COMPOSITION COMPRISING SKIN CARE ACTIVE INGREDIENT AND TWO POLYGLYCERYL FATTY ACID ESTERS L'OREAL (FR) 2022-11-17 WO disclosed
US-20220296605-A1 HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS SAGIMET BIOSCIENCES INC. 2022-09-22 US disclosed
US-20220289736-A1 NLRP3 MODULATORS INNATE TUMOR IMMUNITY INC (US) 2022-09-15 US disclosed
WO-2022165254-A1 KITS FOR DERMAL CARE CHEMISTRYRX (US) 2022-08-04 WO disclosed
US-20220233489-A1 KITS FOR DERMAL CARE CHEMISTRYRX (US) 2022-07-28 US disclosed
CN-114456108-A N-amino acid ethyl ester nicotinamide and preparation method and application thereof 珀莱雅化妆品股份有限公司 2022-05-10 CN disclosed
CN-108883260-B Skin care applicator 宝洁公司 2022-04-29 CN disclosed
US-20220106281-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2022-04-07 US disclosed
WO-2022044974-A2 STABLE COMPOSITION COMPRISING POLYDATIN L'OREAL (FR) 2022-03-03 WO disclosed
CN-113272293-A 2-amino-N-heteroaryl-nicotinamide as NAV1.8 inhibitors 默沙东公司 2021-08-17 CN disclosed
US-20210198252-A1 SMYD INHIBITORS EPIZYME INC (US) 2021-07-01 US disclosed
CN-112689633-A For inhibiting Nav1.8 pyridine carboxamide Compounds 利伯研究所公司 2021-04-20 CN disclosed
US-20210077375-A1 CONCENTRATED COSMETIC COMPOSITION THE BOOTS COMPANY PLC (GB) 2021-03-18 US disclosed
EP-3765020-A1 SPIROCYCLIC ROR-GAMMA MODULATORS Escalier Biosciences B.V. (US) 2021-01-20 EP disclosed
EP-3744729-A1 COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES SEDERMA (FR) 2020-12-02 EP disclosed
US-10842728-B2 Light-absorbing compositions and methods of use ALLELE BIOTECHNOLOGY & PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed
EP-3672520-A1 LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE Allele Biotechnology And Pharmaceuticals, Inc. (US) 2020-07-01 EP disclosed
CN-111246821-A Light absorbing compositions and methods of use 美国绿阳生物技术及医药公司 2020-06-05 CN disclosed
EP-3658234-A1 HEALTH PROMOTING COMPOSITION AND METHODS OF USE SUPPLEMENT RELATED APPLICATIONS Lonza LLC (US) 2020-06-03 EP disclosed
CN-111093770-A Health promoting composition and related application of method using supplement 伦萨有限责任公司 2020-05-01 CN disclosed
EP-3600312-A1 PIPERIDINYL- AND PIPERAZINYL-SUBSTITUTED HETEROAROMATIC CARBOXAMIDES AS MODULATORS OF GPR6 Takeda Pharmaceutical Company Limited (JP) 2020-02-05 EP disclosed
CN-110494432-A Isoquinoline compound, preparation method and its is changing the therapeutical uses in relevant illness to betagalactosidase activity MINORYX THERAPEUTICS S L 2019-11-22 CN disclosed
CN-106854207-B Dai piperazine analog derivative, preparation method, pharmaceutical composition and purposes Shanghai Sai Murrow Biotechnology Co. Ltd. (CN) 2019-10-29 CN disclosed
US-20190322660-A1 SMYD INHIBITORS Epizyme, Inc. 2019-10-24 US disclosed
WO-2019177997-A1 SPIROCYCLIC ROR-GAMMA MODULATORS ESCALIER BIOSCIENCES B.V. (US) 2019-09-19 WO disclosed
EP-3539619-A1 CONCENTRATED COSMETIC COMPOSITION The Boots Company PLC (GB) 2019-09-18 EP disclosed
US-20190269694-A1 HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS SAGIMET BIOSCIENCES INC. 2019-09-05 US disclosed
CN-109851552-A A kind of N- cyanogen methyl -4-(trifluoromethyl) niacinamide synthetic method 京博农化科技有限公司 2019-06-07 CN disclosed
EP-1986750-B1 Use of an extract of Enanthia Chloranta SEDERMA SA (FR) 2019-04-24 EP disclosed
EP-3209279-B1 SKIN CARE PRODUCTS PROCTER & GAMBLE (US) 2019-04-24 EP disclosed
US-10266526-B2 Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer Epizyme, Inc. (US) 2019-04-23 US disclosed
WO-2019046735-A1 HEALTH PROMOTING COMPOSITION AND METHODS OF USE SUPPLEMENT RELATED APPLICATIONS LONZA INC. (US) 2019-03-07 WO disclosed
WO-2019040532-A1 LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE ALLELE BIOTECHNOLOGY & PHARMACEUTICALS, INC. (US) 2019-02-28 WO disclosed
US-10159636-B2 Cosmetic composition containing acetylated oligoglucuronans SEDERMA, S.A.S. (FR) 2018-12-25 US disclosed
CN-108883260-A skin care applicator 宝洁公司 2018-11-23 CN disclosed
US-10130577-B2 Personal care compositions THE PROCTER & GAMBLE COMPANY (US) 2018-11-20 US disclosed
CN-105683179-B inhibitors of plasma kallikrein 卡尔维斯塔制药有限公司 2018-10-26 CN disclosed
WO-2018183145-A1 PIPERIDINYL- AND PIPERAZINYL-SUBSTITUTED HETEROAROMATIC CARBOXAMIDES AS MODULATORS OF GPR6 TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-10-04 WO disclosed
US-20180264245-A1 Skin Care Applicator OBJ LIMITED (AU) 2018-09-20 US disclosed
WO-2018169924-A1 SKIN CARE APPLICATOR THE PROCTER & GAMBLE COMPANY (US) 2018-09-20 WO disclosed
CN-105026375-B SHIP1 modulators and methods related thereto 阿奎诺克斯药物(加拿大)公司 2018-06-05 CN disclosed
EP-2382230-B1 PEPTIDES KXK, COMPOSITIONS LES COMPRENANT ET UTILISATIONS COSMETIQUES ET DERMO-PHARMACEUTIQUES. SEDERMA SA (FR) 2018-05-23 EP disclosed
EP-2419076-B1 COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES SEDERMA SA (FR) 2018-02-28 EP disclosed
US-20180049962-A1 LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, INC. 2018-02-22 US disclosed
CN-107709314-A Efflux pump inhibitor and its therapeutic use 巴斯利尔药物国际股份公司 2018-02-16 CN disclosed
US-20170355695-A1 SMYD Inhibitors Epizyme, Inc. (US) 2017-12-14 US disclosed
EP-2056783-B1 HAIR CARE COMPOSITIONS THAT CAN INCREASE THE APPEARANCE OF THICKER AND FULLER HAIR PROCTER & GAMBLE (US) 2017-11-22 EP disclosed
EP-2268259-B1 METHODS FOR PREVENTING OXIDATIVE DAMAGE OF HAIR ATTRIBUTED TO THE PRESENCE OF FUNGI IN THE HAIR FOLLICLE PROCTER & GAMBLE (US) 2017-11-15 EP disclosed
CN-107344936-A Triazole pyridazine analog derivative, its preparation method, pharmaceutical composition and purposes 如东赛默罗生物科技有限公司 2017-11-14 CN disclosed
EP-3209279-A1 SKIN CARE PRODUCTS The Procter and Gamble Company (US) 2017-08-30 EP disclosed
US-9737472-B2 Light-absorbing compositions and methods of use ALLELE BIOTECHNOLOGY & PHARMACEUTICALS, INC. (US) 2017-08-22 US disclosed
EP-1879538-B1 TOPICAL USE OF TEPRENONE SEDERMA SA (FR) 2017-08-02 EP disclosed
EP-3191823-A1 SABRE NMR ANALYSIS METHOD Stichting Katholieke Universiteit Nijmegen (NL) 2017-07-19 EP disclosed
US-20170172886-A1 Personal Care Compositions PROCTER & GAMBLE (US) 2017-06-22 US disclosed
CN-106854207-A Dai piperazine analog derivative, its preparation method, pharmaceutical composition and purposes 上海赛默罗生物科技有限公司 2017-06-16 CN disclosed
EP-1984387-B1 POLYPEPTIDES KXK AND THEIR USE SEDERMA SA (FR) 2017-05-31 EP disclosed
EP-2209460-B1 COSMETIC COMPOSITION COMPRISING HYDROXYMETHIONINE AND 3-AMINOPROPANESULFONIC ACID SEDERMA SA (FR) 2017-05-10 EP disclosed
EP-2510982-B1 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE PEPTIDE WITH AT LEAST ONE IMMOBILIZED AROMATIC CYCLE SEDERMA SA (FR) 2017-04-26 EP disclosed
US-9616011-B2 Personal care compositions THE PROCTER & GAMBLE COMPANY (US) 2017-04-11 US disclosed
EP-3148985-A1 NOVEL COMPOUNDS GlaxoSmithKline Intellectual Property Development Limited (GB) 2017-04-05 EP disclosed
EP-1904020-B1 SLIMMING COSMETIC COMPOSITIONS SEDERMA SA (FR) 2016-10-26 EP disclosed
EP-2736886-B1 SUBSTITUTED QUINOLINES AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2016-09-14 EP disclosed
US-20160193132-A1 LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE ALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC (US) 2016-07-07 US disclosed
CN-105683179-A Inhibitors of plasma kallikrein 卡尔维斯塔制药有限公司 2016-06-15 CN disclosed
EP-3024432-A1 METHOD OF PROTECTING SKIN FROM AN ENVIRONMENTAL STRESSOR The Procter & Gamble Company (US) 2016-06-01 EP disclosed
EP-2015849-B1 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE PEPTIDE WITH AT LEAST ONE AROMATIC CYCLE SEDERMA SA (FR) 2016-04-06 EP disclosed
WO-2016044567-A1 SKIN CARE PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2016-03-24 WO disclosed
US-20160081902-A1 PERSONAL CARE COMPOSITIONS OSBORNE ROSEMARIE (US) 2016-03-24 US disclosed
WO-2016038013-A1 SABRE NMR ANALYSIS METHOD STICHTING KATHOLIEKE UNIVERSITEIT (NL) 2016-03-17 WO disclosed
US-20160074643-A1 SKIN CARE PRODUCTS THE PROCTER & GAMBLE COMPANY 2016-03-17 US disclosed
EP-2968305-A1 ORAL ELECTROLYTE SOLUTION CONTAINING LACTOFERRIN AND USES THEREOF MJN U.S. Holdings, LLC (US) 2016-01-20 EP disclosed
US-9205284-B2 Light-absorbing compositions and methods of use ALLELE BIOTECHNOLOGY & PHARMACEUTICALS, INC. (US) 2015-12-08 US disclosed
WO-2015180613-A1 NOVEL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2015-12-03 WO disclosed
US-9199937-B2 Substituted quinolines and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-12-01 US disclosed
EP-2435020-B1 COSMETIC USE OF TYR-ARG DIPEPTIDE TO COMBAT CUTANEOUS SAGGING SEDERMA SA (FR) 2015-09-02 EP disclosed
US-20150196475-A1 Cosmetic Composition Containing Acetylated Oligoglucuronans SEDERMA (FR) 2015-07-16 US disclosed
US-9050477-B2 Cosmetic compositions comprising oridonin and new cosmetic uses SEDERMA (FR) 2015-06-09 US disclosed
EP-2846874-A2 HAIR TREATMENT COMPRISING SILICONE GRAFTED STARCH The Procter & Gamble Company (US) 2015-03-18 EP disclosed
US-20150065489-A1 Substituted Quinolines and Their Use As Medicaments BOEHRINGER INGELHEIM INT (DE) 2015-03-05 US disclosed
WO-2015012978-A1 METHOD OF PROTECTING SKIN FROM AN ENVIRONMENTAL STRESSOR THE PROCTER & GAMBLE COMPANY (US) 2015-01-29 WO disclosed
US-20150023897-A1 METHOD OF PROTECTING SKIN FROM OXIDATIVE STRESS THE PROCTER & GAMBLE COMPANY 2015-01-22 US disclosed
US-8871717-B2 Personal care compositions THE PROCTER & GAMBLE COMPANY (US) 2014-10-28 US disclosed
US-8846019-B2 Use of protoberberines as an active substance regulating the pilosebaceous unit SEDERMA (FR) 2014-09-30 US disclosed
WO-2014143471-A1 ORAL ELECTROLYTE SOLUTION CONTAINING LACTOFERRIN AND USES THEREOF MJN U.S. HOLDINGS LLC (US) 2014-09-18 WO disclosed
US-20140255365-A1 Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof MEAD JOHNSON NUTRITION COMPANY (US) 2014-09-11 US disclosed
EP-2560612-B1 METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS INTENDED FOR ORAL ADMINISTRATION COMPRISING ONE OR MORE ACTIVE INGREDIENTS AND THE COMPOSITIONS COMPRISING SAME SANOFI SA (FR) 2014-09-03 EP disclosed
EP-1841405-B1 COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN EUGLENA EXTRACT SEDERMA SA (FR) 2014-07-30 EP disclosed
CN-101910168-B Tropane compounds EXELIXIS INC 2014-07-30 CN disclosed
CN-101360421-B Nicotinoyl riboside compositions and methods of use CORNELL RES FOUNDATION INC 2014-06-18 CN disclosed
US-8741357-B2 Cosmetic or dermopharmaceutical composition comprising an euglena extract SEDERMA SAS (FR) 2014-06-03 US disclosed
EP-2105123-B1 Skin care compositions containing a sugar amine and a vitamin B3 compound PROCTER & GAMBLE (US) 2014-05-21 EP disclosed
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-04-17 US disclosed
US-8697656-B2 Compounds, in particular peptides, compositions comprising them and cosmetic and dermo-pharmaceutical uses SEDERMA (FR) 2014-04-15 US disclosed
CN-101384544-B Substituted cyclohexylmethyl derivatives GRUENENTHAL GMBH 2014-01-22 CN disclosed
WO-2013170004-A2 HAIR TREATMENT COMPRISING SILICONE GRAFTED STARCH THE PROCTER & GAMBLE COMPANY (US) 2013-11-14 WO disclosed
US-20130302267-A1 HAIR TREATMENT COMPRISING SILICONE GRAFTED STARCH THE PROCTER & GAMBLE COMPANY (US) 2013-11-14 US disclosed
US-8575204-B2 Nicotinamide derivates useful as P38 inhibitors GLAXOSMITHKLINE LLC (US) 2013-11-05 US disclosed
US-20130251794-A1 Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same SANOFI (FR) 2013-09-26 US disclosed
US-8507649-B2 Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle SEDERMA (FR) 2013-08-13 US disclosed
EP-2593102-A1 OXAZOLE DERIVATIVES USEFUL AS MODULATORS OF FAAH Merck Sharp & Dohme Corp. (US) 2013-05-22 EP disclosed
EP-2574328-A2 Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair The Procter and Gamble Company (US) 2013-04-03 EP disclosed
US-8404648-B2 Polypeptides KXK and their use SEDERMA (FR) 2013-03-26 US disclosed
EP-1960421-B1 NEW POLYPEPTIDES AND THEIR USE SEDERMA SA (FR) 2013-03-13 EP disclosed
US-8388939-B2 Moisturizing cosmetic composition comprising a combination of homarine and erythritol SEDERMA, S.A.S. (FR) 2013-03-05 US disclosed
CN-102946857-A Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same SANOFI AVENTIS 2013-02-27 CN disclosed
US-8377663-B2 Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid SEDERMA, S.A.S. (FR) 2013-02-19 US disclosed
WO-2013014060-A1 SUBSTITUTED QUINOLINES AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-31 WO disclosed
US-8361516-B2 Composition comprising sarsasapogenin SEDERMA (FR) 2013-01-29 US disclosed
EP-2510982-A1 Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle Sederma (FR) 2012-10-17 EP disclosed
US-20120258185-A1 HAIR CARE COMPOSITIONS, METHODS, AND ARTICLES OF COMMERCE THAT CAN INCREASE THE APPEARANCE OF THICKER AND FULLER HAIR OBLONG JOHN ERICH (US) 2012-10-11 US disclosed
US-8252818-B2 Nicotinamide derivatives useful as P38 inhibitors GLAXOSMITHKLINE LLC (US) 2012-08-28 US disclosed
EP-2252375-B1 Moisturizing cosmetic composition comprising a combination of homarine and erythritol SEDERMA SA (FR) 2012-08-08 EP disclosed
CN-101220068-B A set of geldanamycin derivant and method for preparing the same INST OF MEDICINAL BIOTECHNOLOGY ACADEMY OF MEDICAL SCIENCES 2012-06-13 CN disclosed
US-20120142744-A1 NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND PYRIDINE CARBOXY DERIVATIVES ASTION DERMATOLOGY A/S 2012-06-07 US disclosed
US-20120108565-A1 PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2012-05-03 US disclosed
US-20120093737-A1 LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, INC. 2012-04-19 US disclosed
EP-2435020-A2 COSMETIC USE OF TYR-ARG DIPEPTIDE TO COMBAT CUTANEOUS SAGGING Sederma (FR) 2012-04-04 EP disclosed
US-20120076842-A1 COSMETIC USE OF TYR-ARG DIPEPTIDE TO COMBAT CUTANEOUS SAGGING SEDERMA (FR) 2012-03-29 US disclosed
EP-2419076-A2 COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES Sederma (FR) 2012-02-22 EP disclosed
US-20120028916-A1 COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES SEDERMA (FR) 2012-02-02 US disclosed
US-20120014887-A1 NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES SEDERMA (FR) 2012-01-19 US disclosed
US-8084049-B2 Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives ASTION DERMATOLOGY A/S (DK) 2011-12-27 US disclosed
EP-2382230-A2 KXK-PEPTIDE COMPOSITIONS FOR COSMETIC AND DERMO-PHARMACEUTIC USES Sederma (FR) 2011-11-02 EP disclosed
EP-2382231-A2 NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES Sederma (FR) 2011-11-02 EP disclosed
US-20110250276-A1 Cosmetic Composition Containing Acetylated Oligoglucuronans SEDERMA, S.A.S. (FR) 2011-10-13 US disclosed
EP-2367852-A1 COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS Sederma (FR) 2011-09-28 EP disclosed
US-20110183914-A1 Personal Care Compositions OSBORNE ROSEMARIE 2011-07-28 US disclosed
EP-2344114-A2 HAIR CARE COMPOSITIONS, METHODS, AND ARTICLES OF COMMERCE THAT CAN INCREASE THE APPEARANCE OF THICKER AND FULLER HAIR The Procter & Gamble Company (US) 2011-07-20 EP disclosed
EP-2046283-B1 COMPOSITION COMPRISING SARSASAPOGENIN SEDERMA SA (FR) 2011-03-16 EP disclosed
US-7902373-B2 asthma; for treating prostaglandin D2 mediated diseases; e.g. 6-(3-fluorophenyl)-N-[1-(1-methyl-1H-tetrazol-5-yl)piperidin-4-yl]nicotinamide PFIZER INC (US) 2011-03-08 US disclosed
US-20110045036-A1 Cosmetic Compositions Comprising at Least One Peptide with at Least One Immobilized Aromatic Cycle SEDERMA (FR) 2011-02-24 US disclosed
US-20110033507-A1 Polypeptides KXK and Their Use SEDERMA (FR) 2011-02-10 US disclosed
US-20110002865-A1 MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL SEDERMA, S.A.S. (FR) 2011-01-06 US disclosed
EP-2268259-A2 HAIR CARE COMPOSITIONS FOR PREVENTING OXIDATIVE DAMAGE TO HAIR, METHODS OF USE, AND METHODS OF MARKETING SUCH COMPOSITIONS The Procter & Gamble Company (US) 2011-01-05 EP disclosed
CN-101910168-A Tropane compounds EXELIXIS INC 2010-12-08 CN disclosed
WO-2010136965-A2 COSMETIC USE OF TYR-ARG DIPEPTIDE TO COMBAT CUTANEOUS SA SEDERMA (FR) 2010-12-02 WO disclosed
EP-2252375-A1 MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL Sederma (FR) 2010-11-24 EP disclosed
US-20100285077-A1 COSMETIC COMPOSITION COMPRISING HYDROXYMETHIONINE AND 3-AMINOPROPANESULFONIC ACID SEDERMA, S.A.S. (FR) 2010-11-11 US disclosed
WO-2010119423-A2 COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES SEDERMA (FR) 2010-10-21 WO disclosed
US-20100227896-A1 USE OF VITAMIN PP COMPOUNDS ASTELLAS DEUTSCHLAND GMBH (DE) 2010-09-09 US disclosed
US-20100215661-A1 NICOTINAMIDE DERIVATES USEFUL AS P38 INHIBITORS SMITHKLINE BEECHAM CORPORATION 2010-08-26 US disclosed
US-20100215652-A1 NICOTINAMIDE DERIVATES USEFUL AS P38 INHIBITORS ASTON NICOLA MARY 2010-08-26 US disclosed
EP-2209460-A2 COSMETIC COMPOSITION COMPRISING HYDROXYMETHIONINE AND 3-AMINOPROPANESULFONIC ACID Sederma (FR) 2010-07-28 EP disclosed
WO-2010082177-A2 NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES SEDERMA (FR) 2010-07-22 WO disclosed
WO-2010082176-A2 COSMETIC COMPOSITION CONTAINING KXK TYPE PEPTIDES AND USES SEDERMA (FR) 2010-07-22 WO disclosed
WO-2010082175-A2 NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES SEDERMA (FR) 2010-07-22 WO disclosed
WO-2010067327-A1 COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS SEDERMA (FR) 2010-06-17 WO disclosed
WO-2010054343-A2 HAIR CARE COMPOSITIONS, METHODS, AND ARTICLES OF COMMERCE THAT CAN INCREASE THE APPEARANCE OF THICKER AND FULLER HAIR THE PROCTER & GAMBLE COMPANY (US) 2010-05-14 WO disclosed
US-20100120871-A1 HAIR CARE COMPOSITIONS, METHODS, AND ARTICLES OF COMMERCE THAT CAN INCREASE THE APPEARANCE OF THICKER AND FULLER HAIR THE PROCTER & GAMBLE COMPANY 2010-05-13 US disclosed
US-7709506-B2 Nicotinamide derivatives useful as p38 inhibitors GLAXOSMITHKLINE LLC (US) 2010-05-04 US disclosed
WO-2010044076-A2 COSMETIC AND TOPICAL USE OF XANTHOHUMOL INCLUDING BRIGHTENING SKIN COMPLEXION AND REDUCING CUTANEOUS REDNESS SEDERMA (FR) 2010-04-22 WO disclosed
WO-2009135006-A2 HAIR CARE COMPOSITIONS FOR PREVENTING OXIDATIVE DAMAGE TO HAIR, METHODS OF USE, AND METHODS OF MARKETING SUCH COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2009-11-05 WO disclosed
US-20090274642-A1 Hair Care Compositions for Preventing Oxidative Damage to Hair, Methods of Use, and Methods of Marketing Such Compositions THE PROCTER & GAMBLE COMPANY 2009-11-05 US disclosed
US-20090269395-A1 USE OF PROTOBERBERINES AS AN ACTIVE SUBSTANCE REGULATING THE PILOSEBACEOUS UNIT SEDERMA (FR) 2009-10-29 US disclosed
US-20090253666-A1 COMPOSITION COMPRISING SARSASAPOGENIN SEDERMA (FR) 2009-10-08 US disclosed
EP-2105123-A2 Skin care compositions containing a sugar amine and a vitamin B3 compound The Procter & Gamble Company (US) 2009-09-30 EP disclosed
WO-2009104118-A1 MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL SEDERMA (FR) 2009-08-27 WO disclosed
US-20090214607-A1 Topical use of teprenone SEDERMA (FR) 2009-08-27 US disclosed
EP-1032352-B2 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE PROCTER & GAMBLE (US) 2009-05-13 EP disclosed
EP-2056783-A2 HAIR CARE COMPOSITIONS THAT CAN INCREASE THE APPEARANCE OF THICKER AND FULLER HAIR The Procter and Gamble Company (US) 2009-05-13 EP disclosed
EP-2046283-A2 COMPOSITION COMPRISING SARSASAPOGENIN SEDERMA (FR) 2009-04-15 EP disclosed
EP-0983049-B2 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE PROCTER & GAMBLE (US) 2009-04-15 EP disclosed
US-7514456-B2 Nicotinamide derivatives useful as p38 inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2009-04-07 US disclosed
WO-2009034537-A2 COSMETIC COMPOSITION COMPRISING HYDROXYMETHIONINE AND 3-AMINOPROPANESULFONIC ACID SEDERMA (FR) 2009-03-19 WO disclosed
CN-101360421-A Nicotinoyl riboside compositions and methods of use CORNELL RES FOUNDATION INC (US) 2009-02-04 CN disclosed
EP-2015849-A2 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE PEPTIDE WITH AT LEAST ONE AROMATIC CYCLE Sederma (FR) 2009-01-21 EP disclosed
US-20090017147-A1 Cosmetic or Dermopharmaceutical Composition Comprising an Euglena Extract SEDERMA (FR) 2009-01-15 US disclosed
EP-1986750-A2 USE OF PROTOBERBERINES AS AN ACTIVE SUBSTANCE REGULATING THE PILOSEBACEOUS UNIT SEDERMA (FR) 2008-11-05 EP disclosed
EP-1984387-A1 NEW POLYPEPTIDES KXK AND THEIR USE Sederma (FR) 2008-10-29 EP disclosed
US-7419655-B2 Skin care products KIMBERLY-CLARK WORLDWIDE, INC. (US) 2008-09-02 US disclosed
EP-1960421-A1 NEW POLYPEPTIDES AND THEIR USE Sederma S.A. (FR) 2008-08-27 EP disclosed
CN-101220068-A A set of geldanamycin derivant and method for preparing the same INST MEDICINAL BIOTECHNOLOGY (CN) 2008-07-16 CN disclosed
US-20080146569-A1 Nicotinamide Derivatives PFIZER INC. 2008-06-19 US disclosed
EP-1904020-A2 NEW SLIMMING COSMETIC COMPOSITIONS Sederma S.A.S. (FR) 2008-04-02 EP disclosed
US-20080059313-A1 Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair THE PROCTER & GAMBLE COMPANY 2008-03-06 US disclosed
WO-2008027541-A2 HAIR CARE COMPOSITIONS THAT CAN INCREASE THE APPEARANCE OF THICKER AND FULLER HAIR THE PROCTER & GAMBLE COMPANY (US) 2008-03-06 WO disclosed
US-20080044494-A1 Skin care compositions containing silicone elastomers ROBINSON LARRY R 2008-02-21 US disclosed
WO-2008015639-A2 COMPOSITION COMPRISING SARSASAPOGENIN SEDERMA (FR) 2008-02-07 WO disclosed
US-20080025932-A1 Skin care compositions containing a sugar amine BISSETT DONALD L 2008-01-31 US disclosed
EP-1879538-A1 TOPICAL USE OF TEPRENONE Sederma (FR) 2008-01-23 EP disclosed
EP-1299080-B1 SKIN CARE COMPOSITIONS CONTAINING SILICONE ELASTOMERS PROCTER & GAMBLE (US) 2007-12-12 EP disclosed
WO-2007129270-A2 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE PEPTIDE WITH AT LEAST ONE IMMOBILIZED AROMATIC CYCLE SEDERMA (FR) 2007-11-15 WO disclosed
EP-1841405-A1 COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN EUGLENA EXTRACT Sederma (FR) 2007-10-10 EP disclosed
EP-1357819-B1 MASK COMPOSITION PROCTER & GAMBLE (US) 2007-10-10 EP disclosed
WO-2007093839-A1 NEW POLYPEPTIDES KXK AND THEIR USE SEDERMA (FR) 2007-08-23 WO disclosed
WO-2007077541-A2 COSMETIC COMPOSITION COMPRISING GLAUCINE AND ITS USE SEDERMA (FR) 2007-07-12 WO disclosed
WO-2007068998-A1 NEW POLYPEPTIDES AND THEIR USE SEDERMA (FR) 2007-06-21 WO disclosed
US-20070128145-A1 Amino acid adducts for percutaneous delivery of vitamin B3 THE PROCTER & GAMBLE COMPANY 2007-06-07 US disclosed
WO-2007064762-A2 CONJUGATES OF AMINO ACIDS AND VITAMIN B3 FOR PERCUTANEOUS DELIVERY OF VITAMIN B3 THE PROCTER & GAMBLE COMPANY (US) 2007-06-07 WO disclosed
EP-1792630-A1 Conjugates of amino acids and vitamin B3 for percutaneous delivery of vitamin B3 The Procter & Gamble Company (US) 2007-06-06 EP disclosed
WO-2007029187-A2 USE OF PROTOBERBERINES AS AN ACTIVE SUBSTANCE REGULATING THE PILOSEBACEOUS UNIT SEDERMA (FR) 2007-03-15 WO disclosed
WO-2007010478-A2 SLIMMING COSMETIC COMPOSITIONS SEDERMA (FR) 2007-01-25 WO disclosed
US-20070020220-A1 A dipeptide with a C terminal threonine formulated for oral or topical administration or injection; cosmetics for hair, skin, and nails; improved aging resistance PROCTER & GAMBLE COMPANY, THE 2007-01-25 US disclosed
US-20060276516-A1 Nicotinamide Derivatives Useful as p38 Inhibitors SMITHKLINE BEECHAM CORPORATION 2006-12-07 US disclosed
US-20060264479-A1 Nicotinamide Derivatives Useful as p38 Inhibitors SMITHKLINE BEECHAM CORPORATION 2006-11-23 US disclosed
WO-2006120646-A1 TOPICAL USE OF TEPRENONE SEDERMA (FR) 2006-11-16 WO disclosed
US-7125898-B2 Nicotinamide derivatives useful as p38 inhibitors. SMITHKLINE BEECHAM CORPORATION (US) 2006-10-24 US disclosed
EP-1560589-B1 NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND NIACINAMIDE ASTION DERMATOLOGY AS (DK) 2006-10-04 EP disclosed
US-20060193809-A1 Skin care compositions containing a sugar amine cross reference to related application BISSETT DONALD L 2006-08-31 US disclosed
US-20060188467-A1 Skin care composition containing a sugar amine BISSETT DONALD L 2006-08-24 US disclosed
US-20060188462-A1 Skin care compositions containing a sugar amine BISSETT DONALD L 2006-08-24 US disclosed
WO-2006075311-A1 COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN EUGLENA EXTRACT SEDERMA (FR) 2006-07-20 WO disclosed
EP-1370229-B1 ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING A SOLID, WATER-SOLUBLE, SKIN ACTIVE AGENT AND GLYCERIN PROCTER & GAMBLE (US) 2006-06-07 EP disclosed
US-7033579-B1 Anhydrous antiperspirant and deodorant compositions containing solid vitamin B3 particulates and glycerin THE PROCTER & GAMBLE COMPANY (US) 2006-04-25 US disclosed
US-20060069131-A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives ASTION DERMATOLOGY A/S 2006-03-30 US disclosed
EP-1640011-A1 Novel complexes of fatty acid esters of polyhydroxylalkanes and pyridine carboxy derivates Astion Dermatology A/S (DK) 2006-03-29 EP disclosed
EP-1079832-B1 USE OF VITAMIN PP COMPOUNDS KLINGE CO CHEM PHARM FAB (DE) 2005-11-30 EP disclosed
CN-1674921-A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives ASTION DERMATOLOGY AS (DK) 2005-09-28 CN disclosed
EP-1150645-B1 COSMETIC COMPOSITIONS CONTAINING VITAMIN B3 PROCTER & GAMBLE (US) 2005-08-24 EP disclosed
EP-0983051-B1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE PROCTER & GAMBLE (US) 2005-08-24 EP disclosed
US-20050176964-A1 Nicotinamide derivatives useful as p38 inhibitors GLAXOSMITHKLINE LLC 2005-08-11 US disclosed
US-20050013784-A1 Mask composition THE PROCTER & GAMBLE COMPANY (US) 2005-01-20 US disclosed
US-20040192649-A1 Skin care compositions containing a sugar amine BISSETT DONALD LYNN (US) 2004-09-30 US disclosed
WO-2004024118-A1 SKIN CARE PRODUCTS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2004-03-25 WO disclosed
US-20040047827-A1 Skin care products KIMBERLY-CLARK WORLDWIDE, INC. 2004-03-11 US disclosed
EP-1063967-B1 COMPOSITIONS FOR REGULATING SKIN APPEARANCE PROCTER & GAMBLE (US) 2004-02-11 EP disclosed
EP-1152733-B1 COSMETIC COMPOSITIONS CONTAINING VITAMIN B3 PROCTER & GAMBLE (US) 2004-01-07 EP disclosed
EP-1372600-A2 SKIN CARE COMPOSITIONS CONTAINING A SUGAR AMINE The Procter & Gamble Company (US) 2004-01-02 EP disclosed
EP-1370229-A1 ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING A SOLID, WATER-SOLUBLE, SKIN ACTIVE AGENT AND GLYCERIN The Procter & Gamble Company (US) 2003-12-17 EP disclosed
EP-1367985-A2 ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING A SOLID, WATER-SOLUBLE, SKIN ACTIVE AGENT THE PROCTER & GAMBLE COMPANY (US) 2003-12-10 EP disclosed
EP-1357819-A2 MASK COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2003-11-05 EP disclosed
EP-1152732-B1 COSMETIC COMPOSITIONS CONTAINING VITAMIN B3 PROCTER & GAMBLE (US) 2003-11-05 EP disclosed
EP-0896522-B1 METHODS OF REGULATING SKIN APPEARANCE WITH VITAMIN B 3 COMPOUND PROCTER & GAMBLE (US) 2003-10-22 EP disclosed
EP-0983050-B1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE PROCTER & GAMBLE (US) 2003-09-10 EP disclosed
EP-0983053-B1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE PROCTER & GAMBLE (US) 2003-07-16 EP disclosed
EP-1139975-B1 TRANSPARENT SKIN CARE COMPOSITIONS PROCTER & GAMBLE (US) 2003-06-18 EP disclosed
EP-1178772-B1 TRANSPARENT MICRO EMULSION PROCTER & GAMBLE (US) 2003-06-04 EP disclosed
EP-0983049-B1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE PROCTER & GAMBLE (US) 2003-05-02 EP disclosed
US-6555119-B1 Two or more nonionic surfactants, two or more oily components, a water-soluble high molecular weight polymer, and a cosmetically acceptable carrier. THE PROCTER & GAMBLE COMPANY 2003-04-29 US disclosed
EP-1032352-B1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE PROCTER & GAMBLE (US) 2003-04-23 EP disclosed
EP-1299080-A2 SKIN CARE COMPOSITIONS CONTAINING SILICONE ELASTOMERS THE PROCTER & GAMBLE COMPANY (US) 2003-04-09 EP disclosed
EP-1071515-B1 SKIN CARE KIT PROCTER & GAMBLE (US) 2003-03-26 EP disclosed
US-20030049212-A1 Skin care compositions containing silicone elastomers THE PROCTER & GAMBLE COMPANY 2003-03-13 US disclosed
US-6528071-B2 Containing vitamin B3 THE PROCTER & GAMBLE COMPANY 2003-03-04 US disclosed
US-20020182237-A1 Skin care compositions containing a sugar amine THE PROCTER & GAMBLE COMPANY 2002-12-05 US disclosed
WO-2002076423-A2 SKIN CARE COMPOSITIONS CONTAINING A SUGAR AMINE THE PROCTER & GAMBLE COMPANY (US) 2002-10-03 WO disclosed
US-6455055-B1 COSMETIC COMPOSITIONS INCLUDING LIPSTICKS, A CRYSTALLINE VITAMIN B.SUB.3 OR NIACIN, AN EMOLLIENT COMPONENT; , OF A SOLIDIFYING AGENT. THE COMPOSITIONS PROVIDE IMPROVED SKIN FEEL OF CRYSTALLINE VITAMIN B3 FOR SKIN THE PROCTER & GAMBLE COMPANY 2002-09-24 US disclosed
WO-2002069924-A1 ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING SOLID VITAMIN B3 PARTICULATES AND GLYCERIN THE PROCTER & GAMBLE COMPANY (US) 2002-09-12 WO disclosed
WO-2002069923-A1 ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING A SOLID, WATER-SOLUBLE, SKIN ACTIVE AGENT AND GLYCERIN THE PROCTER & GAMBLE COMPANY (US) 2002-09-12 WO disclosed
WO-2002069916-A2 ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING A SOLID, WATER-SOLUBLE, SKIN ACTIVE AGENT THE PROCTER & GAMBLE COMPANY (US) 2002-09-12 WO disclosed
US-6444647-B1 COMPOSITION COMPRISING SAFE AND EFFECTIVE AMOUNTS OF VITAMIN B3 COMPOUND AND ADDITIONAL SKIN CARE ACTIVE SELECTED FROM FARNESOL AND/OR PHYTANTRIOL, AND DERMATOLOGICALLY ACCEPTABLE EMULSION CARRIER THE PROCTER & GAMBLE COMPANY 2002-09-03 US disclosed
WO-2002062132-A2 MASK COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2002-08-15 WO disclosed
WO-2002062312-A1 MASK COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2002-08-15 WO disclosed
US-H2043-H1 CONTAINING RETINOIDS THE PROCTER & GAMBLE COMPANY 2002-08-06 US disclosed
US-6403072-B1 SUSPENSION; TOPICAL APPLYING THE PROCTER & GAMBLE COMPANY 2002-06-11 US disclosed
US-6383476-B1 Anhydrous antiperspirant and deodorant compositions containing a solid, water-soluble, skin active agent THE PROCTER & GAMBLE COMPANY 2002-05-07 US disclosed
EP-1178772-A1 TRANSPARENT MICRO EMULSION THE PROCTER & GAMBLE COMPANY (US) 2002-02-13 EP disclosed
US-H2013-H1 NIACINAMIDE; COMBINATION OF ISOPROPYL ISOSTEARATE, COTTONSEED OIL FATTY ESTERS OF SUCROSE AND POLYALKYLSILOXANES; GLYCERIN: CETYL ALCOHOL, STEARYL ALCOHOL, STEARIC ACID OR PEG-100 STEARATE STRUCTURING AGENT; ACRYLIC THICKENER THE PROCTER & GAMBLE COMPANY 2002-02-05 US disclosed
WO-2002003952-A2 SKIN CARE COMPOSITIONS CONTAINING SILICONE ELASTOMERS THE PROCTER & GAMBLE COMPANY (US) 2002-01-17 WO disclosed
EP-1171081-A2 SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES THE PROCTER & GAMBLE COMPANY (US) 2002-01-16 EP disclosed
EP-1169016-A1 TRANSPARENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2002-01-09 EP disclosed
EP-1152742-A1 COSMETIC COMPOSITIONS CONTAINING VITAMIN B3 COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2001-11-14 EP disclosed
EP-1152732-A1 COSMETIC COMPOSITIONS CONTAINING VITAMIN B3 THE PROCTER & GAMBLE COMPANY (US) 2001-11-14 EP disclosed
US-6309657-B2 Cosmetic compositions THE PROCTER & GAMBLE COMPANY 2001-10-30 US disclosed
US-20010033850-A1 Cosmetic compositions NOXELL CORPORATION 2001-10-25 US disclosed
EP-1139975-A1 TRANSPARENT SKIN CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-10-10 EP disclosed
EP-1128806-A1 A SKIN LIGHTENING COMPOSITION CONTAINING AN ASCORBIC ACID COMPOUND The Procter & Gamble Company (US) 2001-09-05 EP disclosed
EP-1128805-A1 AN OIL-IN-WATER EMULSION CONTAINING AN ASCORBIC ACID COMPOUND The Procter & Gamble Company (US) 2001-09-05 EP disclosed
US-20010003586-A1 COSMETIC COMPOSITIONS PROCTER & GAMBLE COMPANY, THE 2001-06-14 US disclosed
US-6238678-B1 TOPICAL APPLYING THE PROCTER & GAMBLE COMPANY 2001-05-29 US disclosed
US-6224888-B1 IMPROVING SKIN PENETRATION OF VITAMIN B3 THE PROCTER & GAMBLE COMPANY 2001-05-01 US disclosed
US-6217888-B1 UNIFORM TEXTURE THE PROCTER & GAMBLE COMPANY 2001-04-17 US disclosed
EP-1079832-A1 USE OF VITAMIN PP COMPOUNDS Klinge Pharma GmbH (DE) 2001-03-07 EP disclosed
US-6183761-B1 USING VITAMIN B3 COMPOUNDS AND POLYCYCLIC COMPOUNDS. THE PROCTER & GAMBLE COMPANY 2001-02-06 US disclosed
EP-1071515-A1 SKIN CARE KIT THE PROCTER & GAMBLE COMPANY (US) 2001-01-31 EP disclosed
US-6174533-B1 Skin care compositions and method of improving skin appearance THE PROCTER & GAMBLE COMPANY 2001-01-16 US disclosed
WO-2001000160-A1 COSMETIC COMPOSITIONS CONTAINING VITAMIN B3 THE PROCTER & GAMBLE COMPANY (US) 2001-01-04 WO disclosed
WO-2001000167-A1 COSMETIC COMPOSITIONS CONTAINING VITAMIN B¿3? THE PROCTER & GAMBLE COMPANY (US) 2001-01-04 WO disclosed
WO-2001000162-A1 COSMETIC COMPOSITIONS CONTAINING VITAMIN B3 THE PROCTER & GAMBLE COMPANY (US) 2001-01-04 WO disclosed
WO-2001000159-A1 COSMETIC COMPOSITIONS CONTAINING VITAMIN B3 THE PROCTER & GAMBLE COMPANY (US) 2001-01-04 WO disclosed
EP-1063967-A1 COMPOSITIONS FOR REGULATING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 2001-01-03 EP disclosed
EP-1063965-A1 SKIN MOISTURIZING COMPOSITIONS The Procter & Gamble Company (US) 2001-01-03 EP disclosed
EP-1063994-A1 METHOD OF TREATING SKIN IRRITATION THE PROCTER & GAMBLE COMPANY (US) 2001-01-03 EP disclosed
EP-1063964-A1 MOISTURIZING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-01-03 EP disclosed
EP-1061898-A1 SKIN CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-12-27 EP disclosed
WO-2000062740-A2 SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES THE PROCTER & GAMBLE COMPANY (US) 2000-10-26 WO disclosed
WO-2000061083-A1 TRANSPARENT MICRO EMULSION THE PROCTER & GAMBLE COMPANY (US) 2000-10-19 WO disclosed
WO-2000061098-A1 TRANSPARENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2000-10-19 WO disclosed
EP-1032352-A1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 2000-09-06 EP disclosed
WO-2000047182-A1 COSMETIC COMPOSITIONS CONTAINING VITAMIN B3 COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2000-08-17 WO disclosed
WO-2000047169-A1 COSMETIC COMPOSITIONS CONTAINING VITAMIN B3 THE PROCTER & GAMBLE COMPANY (US) 2000-08-17 WO disclosed
WO-2000037029-A1 TRANSPARENT SKIN CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-06-29 WO disclosed
WO-2000028961-A1 A SKIN LIGHTENING COMPOSITION CONTAINING AN ASCORBIC ACID COMPOUND THE PROCTER & GAMBLE COMPANY (US) 2000-05-25 WO disclosed
WO-2000028960-A1 AN OIL-IN-WATER EMULSION CONTAINING AN ASCORBIC ACID COMPOUND THE PROCTER & GAMBLE COMPANY (US) 2000-05-25 WO disclosed
EP-0986368-A1 SKIN CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-03-22 EP disclosed
WO-2000012059-A1 METHODS OF REDUCING THE IRRITATION ASSOCIATED WITH VITAMIN B3 COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-03-09 WO disclosed
EP-0983050-A1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 2000-03-08 EP disclosed
EP-0983053-A1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 2000-03-08 EP disclosed
EP-0983051-A1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 2000-03-08 EP disclosed
EP-0983049-A1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 2000-03-08 EP disclosed
EP-0983047-A1 SKIN CARE COMPOSITIONS COMPRISING VITAMIN B3 AND A PRESERVATIVE THE PROCTER & GAMBLE COMPANY (US) 2000-03-08 EP disclosed
US-6024942-A SUNSCREEN AGENTS WITH THICKENERS THE PROCTER & GAMBLE COMPANY (US) 2000-02-15 US disclosed
US-6013270-A A SKIN CARE EMULSION CONTAINED WITHIN A DISPENSER, IS PARTICULARLY USEFUL FOR PROVIDING GOOD MOISTURIZATION AND AESTHETICS TO BOTH CREAM AND LOTION USERS THE PROCTER & GAMBLE COMPANY (US) 2000-01-11 US disclosed
US-6001377-A TOPICAL COMPOSITIONS COMPRISING A PARTICULATE MATERIAL, THE PARTICULATE MATERIAL HAVING A REFRACTIVE INDEX OF AT LEAST ABOUT 2 AND A NEAT PRIMARY PARTICLE SIZE OF FROM ABOUT 100 NM TO ABOUT 300 NM, A SKIN CONDITIONING COMPONENT, CARRIER THE PROCTER & GAMBLE COMPANY (US) 1999-12-14 US disclosed
US-5997890-A PARTICULATE MATERIAL HAVING A REFRACTIVE INDEX OF AT LEAST ABOUT 2, WHICH IS TIO2 OR ZRO2; NICOTINAMIDE OR RETINOID THE PROCTER & GAMBLE COMPANY (US) 1999-12-07 US disclosed
US-5997887-A POLYMERIC THICKENER, CHARGED REFLECTIVE PARTICLES OF TIO2, ZNO OR ZRO2 COATED WITH A MATERIAL THAT IMPARTS AN ANIONIC OR CATIONIC CHARGE TO THE PARTICLES THE PROCTER & GAMBLE COMPANY (US) 1999-12-07 US disclosed
WO-1999056720-A1 A COMPOSITION CONTAINING AN ASCORBIC ACID COMPOUND THE PROCTER & GAMBLE COMPANY (US) 1999-11-11 WO disclosed
WO-1999054053-A1 SKIN CARE KIT THE PROCTER & GAMBLE COMPANY (US) 1999-10-28 WO disclosed
WO-1999053920-A1 USE OF VITAMIN PP COMPOUNDS KLINGE PHARMA GMBH (DE) 1999-10-28 WO disclosed
US-5972359-A PIGMENTARY GRADE PARTICULATE MATERIAL HAVING A REFRACTIVE INDEX OF AT LEAST ABOUT 2 AND A NEAT PRIMARY PARTICLE SIZE OF FROM GREATER THAN 100 NM; ESPECIALLY TIO2, ZNO OR ZRO2. THE PROCTER & GAMBLE COMPANY (US) 1999-10-26 US disclosed
WO-1999052502-A1 SKIN CARE COMPOUNDS AND COMPOSITIONS COMPRISING SUCH COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1999-10-21 WO disclosed
WO-1999052501-A1 SKIN CARE COMPOSITIONS COMPRISING A HYDROPHOBIC METAL ION CHELATOR THE PROCTER & GAMBLE COMPANY (US) 1999-10-21 WO disclosed
US-5968528-A VITAMIN B3 COMPOUNDS FOR SKINS THE PROCTER & GAMBLE COMPANY (US) 1999-10-19 US disclosed
WO-1999047114-A1 MOISTURIZING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-09-23 WO disclosed
WO-1999047115-A1 SKIN CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-09-23 WO disclosed
WO-1999047113-A1 COMPOSITIONS FOR REGULATING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 1999-09-23 WO disclosed
WO-1999047117-A1 SKIN MOISTURIZING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-09-23 WO disclosed
WO-1999047116-A1 SKIN CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-09-23 WO disclosed
WO-1999047141-A1 METHOD OF TREATING SKIN IRRITATION THE PROCTER & GAMBLE COMPANY (US) 1999-09-23 WO disclosed
EP-0941057-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-09-15 EP disclosed
EP-0941043-A2 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-09-15 EP disclosed
US-5939082-A REGULATING MAMMALIAN SKIN PORE SIZE BY APPLYING TO THE SKIN NIACINAMIDE AND/OR TOCOPHEROL NICOTINATE THE PROCTER & GAMBLE COMPANY (US) 1999-08-17 US disclosed
WO-1999024001-A1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 1999-05-20 WO disclosed
EP-0896522-A1 METHODS OF REGULATING SKIN APPEARANCE WITH VITAMIN B 3? COMPOUND THE PROCTER & GAMBLE COMPANY (US) 1999-02-17 EP disclosed
WO-1998033786-A9 ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS 1998-12-30 WO disclosed
WO-1998055089-A1 COSMETIC COMPOSITIONS COMPRISING A PROTEINACEOUS MATERIAL AND A POLYOLESTER THE PROCTER & GAMBLE COMPANY (US) 1998-12-10 WO disclosed
WO-1998052535-A1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 1998-11-26 WO disclosed
WO-1998052533-A1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 1998-11-26 WO disclosed
WO-1998052534-A1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 1998-11-26 WO disclosed
WO-1998052530-A1 SKIN CARE COMPOSITIONS COMPRISING VITAMIN B3 AND A PRESERVATIVE THE PROCTER & GAMBLE COMPANY (US) 1998-11-26 WO disclosed
WO-1998052536-A1 SKIN CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-11-26 WO disclosed
WO-1998052532-A1 SKIN CARE COMPOSITIONS AND METHOD OF IMPROVING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 1998-11-26 WO disclosed
WO-1998052529-A1 SKIN CARE COMPOSITIONS COMPRISING VITAMIN B3 AND A SKIN CONDITIONING COMPONENT THE PROCTER & GAMBLE COMPANY (US) 1998-11-26 WO disclosed
WO-1998033786-A1 ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS THE SCRIPPS RESEARCH INSTITUTE (US) 1998-08-06 WO disclosed
WO-1998022085-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-05-28 WO disclosed
WO-1998022075-A2 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-05-28 WO disclosed
WO-1997039733-A1 METHODS OF REGULATING SKIN APPEARANCE WITH VITAMIN B3 COMPOUND THE PROCTER & GAMBLE COMPANY (US) 1997-10-30 WO disclosed
US-RE30309-E N-Alkyl-3-pyridinium-methanol fluorides and derivatives thereof PIERRE FABRE S.A. (FR) 1980-06-17 US disclosed
US-4169923-A HIGH POLYMERS CONTAINING NICOTINIC ACID, PROCESS FOR THEIR PREPARATION AND THEIR USE FERRUTI PAOLO (IT) 1979-10-02 US disclosed
US-4166902-A ESTERIFICATION OF SOLUBLE STARCH WITH NICOTINOYLIMIDAZOLE; SUSTAINED RELEASE BY SLOW HYDROLYSIS IN BIOLOGICAL ENVIRONMENT FERRUTI PAOLO (IT) 1979-09-04 US disclosed
US-4098879-A DENTIFRICES AND ANTICARIES AGENTS PIERRE FABRE S.A. (FR) 1978-07-04 US disclosed
US-4067876-A SUSTAINED RELEASE FERRUTI PAOLO 1978-01-10 US disclosed
US-3987175-A ATHEROSCLEROSIS PIERRE FABRE S.A. (FR) 1976-10-19 US disclosed
US-3987175-A ATHEROSCLEROSIS PIERRE FABRE S.A. (FR) 1976-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10159636-B2 Cosmetic composition containing acetylated oligoglucuronans GLA, FUT5, FUT6 KDM4E 1572/4885ALDH1A1 1145/4885HPGD 2070/4885
US-11827632-B2 NLRP3 modulators NLRP3, NLRP1, NOD1 KDM4E 3882/4885ALDH1A1 3584/4885HPGD 1183/4885
US-12583851-B2 Heteroaryl-substituted pyrazine derivatives as pesticides CBR3, CYCS, CWC15 KDM4E 3282/4885ALDH1A1 2552/4885HPGD 3929/4885
US-20220289736-A1 NLRP3 MODULATORS NLRP3, NLRP1, NOD1 KDM4E 3882/4885ALDH1A1 3584/4885HPGD 1183/4885
US-20160081902-A1 PERSONAL CARE COMPOSITIONS KRT18, CUTA, TTR KDM4E 2189/4885ALDH1A1 4332/4885HPGD 3039/4885
US-20080025932-A1 Skin care compositions containing a sugar amine RBP4, RBP1, RARB KDM4E 1346/4885ALDH1A1 1370/4885HPGD 3428/4885
US-20160074643-A1 SKIN CARE PRODUCTS CUTA, MSH6, POLE3 KDM4E 3580/4885ALDH1A1 3264/4885HPGD 1130/4885
US-11938212-B2 Skin care compositions TTPA, NQO1, ADH4 KDM4E 2740/4885ALDH1A1 426/4885HPGD 18/4885
US-20230023326-A1 HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES DDT, PRXL2A, CAT KDM4E 2574/4885ALDH1A1 3500/4885HPGD 2838/4885
US-20090269395-A1 USE OF PROTOBERBERINES AS AN ACTIVE SUBSTANCE REGULATING THE PILOSEBACEOUS UNIT BROX, CUTA, SHH KDM4E 4161/4885ALDH1A1 3956/4885HPGD 2059/4885
US-20160193132-A1 LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE CYBA, BROX, S100A6 KDM4E 3760/4885ALDH1A1 2131/4885HPGD 1401/4885
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR KDM4E 253/4885ALDH1A1 3942/4885HPGD 3204/4885
US-20250170043-A1 KIT OF COSMETIC COMPOSITIONS CHKA, CHKB, SGMS2 KDM4E 3075/4885ALDH1A1 2229/4885HPGD 1939/4885
US-20240407990-A1 SYNERGISTIC ANTIOXIDANT COMPOSITIONS NQO1, PNPO, PROC KDM4E 4284/4885ALDH1A1 623/4885HPGD 18/4885
US-20010003586-A1 COSMETIC COMPOSITIONS LMNB1, CCNB3, TPRKB KDM4E 3896/4885ALDH1A1 3554/4885HPGD 1508/4885
US-20250161200-A1 COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE SGMS2, SGMS1, CERS2 KDM4E 3605/4885ALDH1A1 2480/4885HPGD 1002/4885
US-20100285077-A1 COSMETIC COMPOSITION COMPRISING HYDROXYMETHIONINE AND 3-AMINOPROPANESULFONIC ACID CUTA, BHMT2, AS3MT KDM4E 937/4885ALDH1A1 3286/4885HPGD 2079/4885
US-20120142744-A1 NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND PYRIDINE CARBOXY DERIVATIVES FFAR3, FADS1, FASN KDM4E 2720/4885ALDH1A1 2033/4885HPGD 76/4885
US-20120014887-A1 NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES CUTA, PLOD3, MC1R KDM4E 4490/4885ALDH1A1 2211/4885HPGD 981/4885
US-20070020220-A1 A dipeptide with a C terminal threonine formulated for oral or topical administration or injection; cosmetics for hair, skin, and nails; improved aging resistance KRT18, PRKDC, TTR KDM4E 1703/4885ALDH1A1 4371/4885HPGD 4239/4885
US-20110183914-A1 Personal Care Compositions KRT18, CUTA, TTR KDM4E 2189/4885ALDH1A1 4332/4885HPGD 3039/4885
US-20040192649-A1 Skin care compositions containing a sugar amine RBP1, RBP4, RARB KDM4E 1813/4885ALDH1A1 1743/4885HPGD 3860/4885
US-20010033850-A1 Cosmetic compositions VDR, S100B, EPHB3 KDM4E 2911/4885ALDH1A1 1655/4885HPGD 1024/4885
US-20250270190-A1 KIT INHIBITORS KIT, ABL1, APC KDM4E 302/4885ALDH1A1 1119/4885HPGD 4173/4885
US-20230320969-A1 Skin Care Compositions TTPA, NQO1, ADH4 KDM4E 2740/4885ALDH1A1 426/4885HPGD 18/4885
US-12351580-B2 NLRP3 modulators NLRP3, NLRP1, NOD1 KDM4E 3882/4885ALDH1A1 3584/4885HPGD 1183/4885
US-20230390178-A1 Skin Care Compositions and Methods of Use CD44, DSG1, CUTA KDM4E 3414/4885ALDH1A1 1863/4885HPGD 198/4885
US-20070128145-A1 Amino acid adducts for percutaneous delivery of vitamin B3 SLC1A5, SLC19A1, PLPBP KDM4E 4343/4885ALDH1A1 1215/4885HPGD 537/4885
US-20120108565-A1 PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS POLI, POLB, POLA1 KDM4E 676/4885ALDH1A1 2042/4885HPGD 563/4885
US-20060264479-A1 Nicotinamide Derivatives Useful as p38 Inhibitors MAPK1, MAPK7, MAPK6 KDM4E 4790/4885ALDH1A1 723/4885HPGD 55/4885
US-20170172886-A1 Personal Care Compositions KRT18, CUTA, TTR KDM4E 2189/4885ALDH1A1 4332/4885HPGD 3039/4885
US-10266526-B2 Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer SMYD3, SMYD2, SNRPD3 KDM4E 141/4885ALDH1A1 1204/4885HPGD 3405/4885
US-20130302267-A1 HAIR TREATMENT COMPRISING SILICONE GRAFTED STARCH SUCLG1, NACA, CROCC KDM4E 1729/4885ALDH1A1 3458/4885HPGD 4199/4885
US-20090274642-A1 Hair Care Compositions for Preventing Oxidative Damage to Hair, Methods of Use, and Methods of Marketing Such Compositions GSR, CAT, GPX1 KDM4E 3148/4885ALDH1A1 504/4885HPGD 870/4885
US-20060188462-A1 Skin care compositions containing a sugar amine RBP4, RBP1, RARB KDM4E 1346/4885ALDH1A1 1370/4885HPGD 3428/4885
US-20110033507-A1 Polypeptides KXK and Their Use NPR3, NGLY1, NPR1 KDM4E 1679/4885ALDH1A1 4431/4885HPGD 2102/4885
US-20120076842-A1 COSMETIC USE OF TYR-ARG DIPEPTIDE TO COMBAT CUTANEOUS SAGGING ARGLU1, CUTA, ARG1 KDM4E 1711/4885ALDH1A1 4229/4885HPGD 2861/4885
US-20090017147-A1 Cosmetic or Dermopharmaceutical Composition Comprising an Euglena Extract CUTA, XPA, BACH1 KDM4E 1723/4885ALDH1A1 3112/4885HPGD 1346/4885
US-20060193809-A1 Skin care compositions containing a sugar amine cross reference to related application RBP4, RBP1, RARB KDM4E 1274/4885ALDH1A1 1286/4885HPGD 3104/4885
US-20100227896-A1 USE OF VITAMIN PP COMPOUNDS PNPO, NAMPT, NAPRT KDM4E 3322/4885ALDH1A1 1385/4885HPGD 54/4885
US-20250161201-A1 COSMETIC COMPOSITION CYP19A1, SHBG, HSD17B11 KDM4E 3942/4885ALDH1A1 2131/4885HPGD 106/4885
US-20220296605-A1 HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS FASN, FADS1, SCD KDM4E 1740/4885ALDH1A1 724/4885HPGD 327/4885
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA KDM4E 361/4885ALDH1A1 3533/4885HPGD 1161/4885
US-20150023897-A1 METHOD OF PROTECTING SKIN FROM OXIDATIVE STRESS HMGB3, SERPINB6, PNPO KDM4E 2713/4885ALDH1A1 811/4885HPGD 474/4885
US-20090253666-A1 COMPOSITION COMPRISING SARSASAPOGENIN FABP4, PLIN1, PLIN3 KDM4E 4142/4885ALDH1A1 2917/4885HPGD 1917/4885
US-20080146569-A1 Nicotinamide Derivatives NNT, NAMPT, NADK KDM4E 3026/4885ALDH1A1 148/4885HPGD 18/4885
US-20180049962-A1 LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE CYBA, BROX, S100A6 KDM4E 3760/4885ALDH1A1 2131/4885HPGD 1401/4885
US-20110045036-A1 Cosmetic Compositions Comprising at Least One Peptide with at Least One Immobilized Aromatic Cycle TYR, XPA, MC1R KDM4E 2698/4885ALDH1A1 2097/4885HPGD 2300/4885
US-20170355695-A1 SMYD Inhibitors SMYD3, SMYD2, SMURF2 KDM4E 137/4885ALDH1A1 1533/4885HPGD 3789/4885
US-20120258185-A1 HAIR CARE COMPOSITIONS, METHODS, AND ARTICLES OF COMMERCE THAT CAN INCREASE THE APPEARANCE OF THICKER AND FULLER HAIR SHH, FSCN1, CUTA KDM4E 678/4885ALDH1A1 1738/4885HPGD 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.